Multiparametric assessment of cardiotoxicity of chemotherapeutic drugs in human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes

被引：0
|
作者：
Mulder, Petra [1 ]
Famili, Farbod [1 ]
de Korte, Tessa [1 ]
Hechard, Celine [1 ]
Braam, Stefan R. [1 ]
Vlaming, Maria L. [1 ]
机构：
[1] Pluriomics, Leiden, Netherlands
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2018年 / 93卷
关键词：
D O I：
10.1016/j.vascn.2018.01.496
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
127
引用
收藏
页码：150 / 151
页数：2
相关论文
共 50 条
  • [1] Cardiotoxicity of chemotherapeutic agents assessed in human embryonic or induced pluripotent stem cell-derived cardiomyocytes
    Mioulane, M.
    Foldes, G.
    Harding, S. E.
    [J]. CARDIOVASCULAR RESEARCH, 2012, 93 : S47 - S47
  • [2] Multiparametric Assessment of the Effects of Tyrosine Kinase Inhibitors (TKIs) on the (Electro) physiology of Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cardiomyocytes
    de Korte, Tessa
    Nacken, Peter
    Pijnenburg, Dirk
    Ruijtenbeek, Rob
    Stevenhagen, Fleur
    Wilbers, Rene
    den Hartogh, Sabine
    Groten, John
    Braam, Stefan
    Vlaming, Maria
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 88 : 236 - 237
  • [3] Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
    Narkar, Akshay
    Willard, James M.
    Blinova, Ksenia
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [4] Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
    Schwach, Verena
    Slaats, Rolf H.
    Passier, Robert
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [5] Use of human induced pluripotent stem cell–derived cardiomyocytes to assess drug cardiotoxicity
    Arun Sharma
    Wesley L. McKeithan
    Ricardo Serrano
    Tomoya Kitani
    Paul W. Burridge
    Juan C. del Álamo
    Mark Mercola
    Joseph C. Wu
    [J]. Nature Protocols, 2018, 13 : 3018 - 3041
  • [6] Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes
    Watanabe, Hitoshi
    Honda, Yayoi
    Deguchi, Jiro
    Yamada, Toru
    Bando, Kiyoko
    [J]. JOURNAL OF TOXICOLOGICAL SCIENCES, 2017, 42 (04): : 519 - 527
  • [7] Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems
    Magdy, Tarek
    Schuldt, Adam J. T.
    Wu, Joseph C.
    Bernstein, Daniel
    Burridge, Paul W.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58, 2018, 58 : 83 - 103
  • [8] Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)
    William P. Bozza
    Kazuyo Takeda
    Wei-Lun Alterovitz
    Chao-Kai Chou
    Rong-Fong Shen
    Baolin Zhang
    [J]. The AAPS Journal, 23
  • [9] microRNAs as signatures of structural cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Gryshkova, V.
    Palmer, J.
    Smith, A.
    Burrier, R.
    Colwell, M.
    Delaunois, A.
    da Costa, A. Nogueira
    Valentin, J. -P.
    [J]. TOXICOLOGY LETTERS, 2018, 295 : S58 - S58
  • [10] Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
    Maillet, Agnes
    Tan, Kim
    Chai, Xiaoran
    Sadananda, Singh N.
    Mehta, Ashish
    Ooi, Jolene
    Hayden, Michael R.
    Pouladi, Mahmoud A.
    Ghosh, Sujoy
    Shim, Winston
    Brunham, Liam R.
    [J]. SCIENTIFIC REPORTS, 2016, 6
12345